Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sigyn Therapeutics Inc (SIGY)

Sigyn Therapeutics Inc (SIGY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sigyn Therapeutics Inc 2305 Historic Decatur Road Ste. 100 San Diego CA 92106 USA

www.sigyntherapeutics.com Employees: 4 P: 619-353-0800

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

Sigyn Therapeutics Inc. is a medical technology company. It is focused on the treatment of life-threatening inflammatory conditions. Sigyn Therapeutics Inc., formerly knonw as Reign Resources Corporation, is headquartered in San Diego, California USA.

Key Statistics

Overview:

Market Capitalization, $K 1,204
Enterprise Value, $K 3,264
Shares Outstanding, K 1,605
Float, K 346
% Float 21.54%
Short Interest, K 0
Short Float 0.02%
Days to Cover 1.00
Short Volume Ratio 0.23
% of Insider Shareholders 78.46%
% of Institutional Shareholders 10.01%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -3,340 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -580 K
EBIT, $ -2,000 K
EBITDA, $ -1,530 K

Growth:

1-Year Return -76.57%
3-Year Return -98.16%
5-Year Return -99.10%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.36 on 11/14/25
Next Earnings Date 04/21/26
Earnings Per Share ttm -4.19
EPS Growth vs. Prev Qtr 60.00%
EPS Growth vs. Prev Year 61.70%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 01/31/24

SIGY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -3,743.20%
Profit Margin % 0.00%
Debt/Equity -0.13
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -3.68
Interest Coverage -2.88
60-Month Beta -0.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar